Denver Health's opioid monitoring program snared in controve

A drug research program at Denver Health has landed in the center of a national controversy, with supporters saying it does vital work to understand the landscape of addiction and opponents accusing the program’s staff of helping opioid makers shift blame from their products.

Related Keywords

Colorado , United States , Denver , Phil Weiser , Andrew Kolodny , Richard Dart , Drug Administration , Hospital Authority , Us Drug Enforcement Agency , Denver Health , Purdue Pharma , Researched Abuse , Addiction Related Surveillance , Public Citizen , Responsible Opioid Prescribing , Enforcement Agency , Colorado Attorney General Phil Weiser ,